[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  GMT EIGHT [@GmtEight08](/creator/twitter/GmtEight08) on x 3069 followers Created: 2025-07-21 08:00:02 UTC AbbVie earned a Buy rating from Morgan Stanley with a $XXX price target, citing low volatility and strong Q1 results: $XXXX EPS (+6.5% YoY) and $13.343B revenue (+9.8% operational growth). XX engagements  **Related Topics** [$13343b](/topic/$13343b) [eps](/topic/eps) [$abbv](/topic/$abbv) [stocks healthcare](/topic/stocks-healthcare) [morgan stanley](/topic/morgan-stanley) [stocks financial services](/topic/stocks-financial-services) [Post Link](https://x.com/GmtEight08/status/1947204909939691860)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
GMT EIGHT @GmtEight08 on x 3069 followers
Created: 2025-07-21 08:00:02 UTC
AbbVie earned a Buy rating from Morgan Stanley with a $XXX price target, citing low volatility and strong Q1 results: $XXXX EPS (+6.5% YoY) and $13.343B revenue (+9.8% operational growth).
XX engagements
Related Topics $13343b eps $abbv stocks healthcare morgan stanley stocks financial services
/post/tweet::1947204909939691860